Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

J Res Educ Indian Med . 2008; 14(1): 41-45


CLINICAL STUDY ON ROLE OF AMALAKI GUTIKA (Emblica officinalis) IN UPPER GIT DISORDERS DURING PREGNANCY W.S.R. TO GARBHAJ CHHARDI (MORNING SICKNESS)

SONI KAPIL, SEEMA SHUKLA, EENA SHARMA.




Abstract

Antiemetics like Promethazine, Prochloroperazine, Chlorpromazine,Triflupromazine etc. and GIT movement regulators like Metoclopramide are commonly used in management of GIT related minor ailments of first trimester like nausea, vomiting etc. collectively called morning sickness. But availability of these drugs to rural mothers is poor. Even in urban areas where conventional therapy is available there is reluctance to take these due to their very chemical nature. To find effective non-toxic and easily available remedy, we tried a folklore drug combination based on Emblica officinalis pulp base named Amalaki gutika in pregnant mothers with different GIT related ailments and compared the results with standard regimen of Doxylamine succinate and Pyridoxine hydrochloride combination most widely used for morning sickness. This is a clinical trial report of comparative study of Amalaki gutika and Doxylamine succinate in pregnancy related morning sickness. After a trial period of 45 days when overall results were evaluated both the formulations are found equally effective.

Key words: Garbhini, Chhardi, Amalaki, Morning sickness, Hrillas, Prasek, Anannabhilasha, Emblica officinalis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.